Samsung Biologics, Foreign Investors Net Sell 3,000 Shares... Stock Price Down 1.33%

Samsung Biologics ranked among the top searched stocks for 13 days in the past month.

As of 1:33 PM on the 18th, Samsung Biologics is trading at 813,000 KRW, down 1.33% from the previous day. This represents a 33.5% increase compared to May 21. Samsung Biologics is known as the holding company for Samsung Group's bio business.

Today, foreigners have sold a net 3,000 shares of Samsung Biologics, and institutions have sold a net 1,000 shares, according to provisional data. Over the past five days, individual investors have bought a net 30,398 shares, while foreigners and institutions have bought a net 1,330 shares and sold a net 39,613 shares, respectively.

On June 15, Samsung Biologics was a market topic with the headline "Record High... Five Consecutive Days of Gains."

[Table] Net Trading Volume of Foreigners and Institutions (Unit: shares)

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.